Octapeptide somatostatin-analogue therapy of Cushing's syndrome

di DE HERDER, W W, LAMBERTS, S
Pubblicazione 1999

Strategies Towards Improving Clinical Outcomes of Peptide Receptor Radionuclide Therapy

di Minczeles, N.S., Hofland, J., de Herder, W.W., Brabander, T.
Pubblicato in Curr Oncol Rep (2021)

Accumulation of plasma triiodothyronine sulfate in rats treated with propylthiouracil.

di Rutgers, M, Bonthuis, F, de Herder, W W, Visser, T J
Pubblicazione 1987

Somatostatin analogue treatment of neuroendocrine tumours.

di de Herder, W. W., van der Lely, A. J., Lamberts, S. W.
Pubblicazione 1996

Pituitary hyperplasia: an uncommon presentation of a common disease

di Neves, C P, Massolt, E T, Peeters, R P, Neggers, S J, de Herder, W W
Pubblicato in Endocrinol Diabetes Metab Case Rep (2015)

Two patients with a neuroendocrine tumour of the small intestine and paraneoplastic myasthenia gravis

di Hermans, M A W, Stelten, B M L, Haak, H R, de Herder, W W, Dercksen, M W
Pubblicazione 2014

Lutetium-labelled peptides for therapy of neuroendocrine tumours

di Kam, B. L. R., Teunissen, J. J. M., Krenning, E. P., de Herder, W. W., Khan, S., van Vliet, E. I., Kwekkeboom, D. J.
Pubblicazione 2012

Salvage peptide receptor radionuclide therapy with [(177)Lu-DOTA,Tyr(3)]octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumours

di van der Zwan, W. A., Brabander, T., Kam, B. L. R., Teunissen, J. J. M., Feelders, R. A., Hofland, J., Krenning, E. P., de Herder, W. W.
Pubblicato in Eur J Nucl Med Mol Imaging (2018)

Inhibition of Human Adrenocortical Cancer Cell Growth by Temozolomide in Vitro and the Role of the MGMT Gene

di Creemers, S. G., van Koetsveld, P. M., van den Dungen, E. S. R., Korpershoek, E., van Kemenade, F. J., Franssen, G. J. H., de Herder, W. W., Feelders, R. A., Hofland, L. J.
Pubblicato in J Clin Endocrinol Metab (2016)

Mifepristone Effects on Tumor Somatostatin Receptor Expression in Two Patients with Cushing's Syndrome due to Ectopic Adrenocorticotropin Secretion

di de Bruin, C., Hofland, L. J., Nieman, L. K., van Koetsveld, P. M., Waaijers, A. M., Sprij-Mooij, D. M., van Essen, M., Lamberts, S. W. J., de Herder, W. W., Feelders, R. A.
Pubblicazione 2012

The role of AIP variants in pituitary adenomas and concomitant thyroid carcinomas in the Netherlands: a nationwide pathology registry (PALGA) study

di Coopmans, E. C., Muhammad, A., Daly, A. F., de Herder, W. W., van Kemenade, F. J., Beckers, A., de Haan, M., van der Lely, A. J., Korpershoek, E., Neggers, S. J. C. M. M.
Pubblicato in Endocrine (2020)

The peripheral blood compartment in patients with Graves' disease: activated T lymphocytes and increased transitional and pre-naive mature B lymphocytes

di Van der Weerd, K, Van Hagen, P M, Schrijver, B, Kwekkeboom, D J, De Herder, W W, Ten Broek, M R J, Postema, P T E, Van Dongen, J J M, Staal, F J T, Dik, W A
Pubblicazione 2013

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [(177)Lu-DOTA(0),Tyr(3)]octreotate

di Kwekkeboom, D. J., Bakker, W. H., Kam, B. L., Teunissen, J. J. M., Kooij, P. P. M., de Herder, W. W., Feelders, R. A., van Eijck, C. H. J., de Jong, M., Srinivasan, A., Erion, J. L., Krenning, E. P.
Pubblicazione 2003

Chromogranin A, Ki-67 index and IGF-related genes in patients with neuroendocrine tumors

di van Adrichem, R C S, Hofland, L J, Feelders, R A, De Martino, M C, van Koetsveld, P M, van Eijck, C H J, de Krijger, R R, Sprij-Mooij, D M, Janssen, J A M J L, de Herder, W W
Pubblicazione 2013

TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system

di Rindi, G., Klöppel, G., Alhman, H., Caplin, M., Couvelard, A., de Herder, W. W., Erikssson, B., Falchetti, A., Falconi, M., Komminoth, P., Körner, M., Lopes, J. M., McNicol, A-M., Nilsson, O., Perren, A., Scarpa, A., Scoazec, J-Y., Wiedenmann, B.
Pubblicazione 2006

A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrin...

di Kulke, M.H., Ruszniewski, P., Van Cutsem, E., Lombard-Bohas, C., Valle, J.W., De Herder, W.W., Pavel, M., Degtyarev, E., Brase, J.C., Bubuteishvili-Pacaud, L., Voi, M., Salazar, R., Borbath, I., Fazio, N., Smith, D., Capdevila, J., Riechelmann, R.P., Yao, J.C.
Pubblicato in Ann Oncol (2017)